Fig. 10: In vivo toxicity evaluation of liposomal nanotheranostics. | Communications Biology

Fig. 10: In vivo toxicity evaluation of liposomal nanotheranostics.

From: Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near‐infrared light mediated cancer therapy

Fig. 10: In vivo toxicity evaluation of liposomal nanotheranostics.The alternative text for this image may have been generated using AI.

a Percentage of hemolysis efficacy of liposomes, gold nanoparticles (AuNPs), and graphene quantum dots (GQDs) loaded liposomal nanotheranostics (NFGL) before and after FA attachment at various concentrations (10–200 µg/mL, n = 3). b Body weight measurements of post-injected various mice groups (n = 3). Both the analysis demonstrate the good biocompatibility and safety of engineered liposomal nanotheranostic agents.

Back to article page